Strategy
MSTR
Coinbase
COIN
Alphabet-A
GOOGL
Alphabet-C
GOOG
NVIDIA
NVDA
US Stock MarketDetailed Quotes
APVO Aptevo Therapeutics
- 2.950
- -0.140-4.53%
Close Mar 4 16:00 ET
- 3.100
- +0.150+5.08%
Post 17:28 ET
4.30MMarket Cap-0.03P/E (TTM)
3.180High2.900Low33.31KVolume3.180Open3.090Pre Close100.73KTurnover2.28%Turnover RatioLossP/E (Static)1.46MShares209.38352wk High0.90P/B4.30MFloat Cap2.90052wk Low--Dividend TTM1.46MShs Float144729.200Historical High--Div YieldTTM9.06%Amplitude2.900Historical Low3.024Avg Price1Lot Size
Aptevo Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -102.77%-23.79M | -9.63%-5.76M | 16.31%-5.22M | -28.11%-6.15M | -245.66%-6.65M | 44.20%-11.73M | 11.55%-5.25M | 9.51%-6.24M | -56.45%-4.8M | 189.23%4.57M |
| Net income from continuing operations | -38.59%-24.13M | -6.93%-6.31M | 19.45%-5.1M | 25.98%-5.88M | -346.45%-6.83M | -316.91%-17.41M | -27.17%-5.9M | 17.15%-6.33M | -128.38%-7.95M | 136.03%2.77M |
| Depreciation and amortization | -37.92%352K | -38.79%71K | -31.71%84K | -39.33%91K | -40.45%106K | -37.07%567K | -27.95%116K | -44.59%123K | -45.65%150K | -26.45%178K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | 100.03%10K | --0 | --0 | --0 | -99.41%10K |
| Change In working capital | -136.96%-1.08M | 214.77%554K | 27.01%-354K | -125.06%-634K | -193.04%-642K | 35.77%2.91M | 109.57%176K | -348.72%-485K | -32.32%2.53M | 1,280.00%690K |
| -Change in receivables | --0 | --0 | --0 | --0 | --0 | 114.78%2.5M | --0 | --0 | --0 | 354.55%2.5M |
| -Change in prepaid assets | 41.83%217K | 314.38%313K | -118.13%-746K | -78.95%312K | 140.19%338K | -56.90%153K | 46.91%-146K | 44.66%-342K | 55.67%1.48M | -384.12%-841K |
| -Change in payables and accrued expense | -296.33%-1.02M | -16.71%324K | 710.53%464K | -178.90%-879K | -1.87%-926K | 231.47%518K | -60.67%389K | -108.82%-76K | 176.99%1.11M | -13.91%-909K |
| -Change in other current assets | 16.59%492K | 18.02%131K | 17.92%125K | 18.63%121K | 11.65%115K | -35.38%422K | 5.71%111K | 1.92%106K | -38.55%102K | -62.95%103K |
| -Change in other current liabilities | -12.61%-768K | -20.22%-214K | -13.87%-197K | -11.90%-188K | -3.68%-169K | -286.34%-682K | -12.66%-178K | -13.07%-173K | -117.63%-168K | 40.94%-163K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -102.77%-23.79M | -9.63%-5.76M | 16.31%-5.22M | -28.11%-6.15M | -245.66%-6.65M | 44.20%-11.73M | 11.55%-5.25M | 9.51%-6.24M | -56.45%-4.8M | 189.23%4.57M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 160.00%15.6M | 120.62%6.72M | 13.01%4.91M | 725.16%3.97M | 99.84%-3K | 329.28%6M | -49.22%3.05M | 968.80%4.34M | 115.14%481K | 62.05%-1.87M |
| Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | 71.74%-3.47M | --0 | --0 | --0 | 67.80%-3.47M |
| Net common stock issuance | 56.13%10.04M | 115,600.00%1.16M | 13.01%4.91M | 725.36%3.97M | --0 | -7.30%6.43M | -99.98%1K | --4.34M | 10.32%481K | --1.6M |
| Proceeds from stock option exercised by employees | 82.57%5.56M | ---- | ---- | ---- | ---- | --3.05M | ---- | ---- | ---- | ---- |
| Net other financing activities | 60.00%-4K | --0 | --0 | ---1K | 62.50%-3K | -100.37%-10K | ---2K | --0 | --0 | -100.14%-8K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 160.00%15.6M | 120.62%6.72M | 13.01%4.91M | 725.16%3.97M | 99.84%-3K | 329.28%6M | -49.22%3.05M | 968.80%4.34M | 115.14%481K | 62.05%-1.87M |
| Net cash flow | ||||||||||
| Beginning cash position | -25.32%16.9M | -59.43%7.75M | -61.60%8.07M | -59.53%10.25M | -25.32%16.9M | -51.11%22.64M | -15.36%19.11M | -29.93%21.01M | -30.13%25.33M | -51.12%22.64M |
| Current changes in cash | -42.88%-8.19M | 143.54%961K | 83.49%-313K | 49.47%-2.18M | -347.09%-6.65M | 75.78%-5.73M | -3,840.68%-2.21M | 74.38%-1.9M | 31.10%-4.32M | 126.79%2.69M |
| End cash Position | -48.45%8.71M | -48.45%8.71M | -59.43%7.75M | -61.60%8.07M | -59.53%10.25M | -25.32%16.9M | -25.32%16.9M | -15.36%19.11M | -29.93%21.01M | -30.13%25.33M |
| Free cash flow | -102.77%-23.79M | -9.63%-5.76M | 16.31%-5.22M | -28.11%-6.15M | -245.66%-6.65M | 44.28%-11.73M | 11.55%-5.25M | 9.57%-6.24M | -55.19%-4.8M | 189.23%4.57M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.